Katie Pawelczak

Company: NERx Biosciences

Job title: VP of Research

Seminars:

Targeting Protein-DNA Interactions in the DNA Damage Response: Lead Identification & Optimization for Novel Inhibitors of Replication Protein A (RPA) & Ku 11:30 am

Understanding how NERx is positioned to lead the first-in-class and first-in-human trials of novel agents targeting RPA and Ku Delving into how RPAi’s synergy with DNA damage-inducing therapeutics and DDR targeted therapies, and a lead candidate has been selected Exploring Ku inhibitors blockage of the Ku-DNA interaction and serve as a novel approach to inhibit…Read more

day: Day Two